Max Robotics — Global Service Robot Directory + US Certification

About

Robert J. Downey is a leading thoracic surgeon whose research focuses on advancing surgical treatments for lung cancer, particularly through minimally invasive techniques and neoadjuvant immunotherapy. His most impactful work, the 2018 study "Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer" (299 citations), demonstrated the safety and feasibility of combining immunotherapy before surgery, reshaping perioperative care for lung cancer patients. Downey has also made critical contributions to understanding surgical outcomes, as shown in his 2022 study on operative time and postoperative complications after pulmonary lobectomy (40 citations), which identified prolonged surgery as a risk factor for morbidity. His expertise extends to robotic video-assisted thoracic surgery (RVATS), where he investigated complications like chylothorax and recurrent laryngeal nerve injury (2015, 18 citations), and he continues to refine patient selection for minimally invasive approaches after neoadjuvant therapy (2024, 12 citations). Through his work, Downey has helped bridge the gap between innovative medical therapies and safe, effective surgical practice, making him a key figure in modern thoracic oncology.